Home/Filings/3/0001209191-20-025497
3//SEC Filing

Topspin Fund L.P. 3

Accession 0001209191-20-025497

CIK 0001796280other

Filed

Apr 22, 8:00 PM ET

Accepted

Apr 23, 8:25 PM ET

Size

13.5 KB

Accession

0001209191-20-025497

Insider Transaction Report

Form 3
Period: 2020-04-23
Holdings
  • Series B Preferred Stock

    Common Stock (231,250 underlying)
  • Series B Preferred Stock

    (indirect: See footnote)
    Common Stock (2,268,750 underlying)
  • Series C Preferred Stock

    Common Stock (497,809 underlying)
  • Series D Preferred Stock

    Common Stock (314,815 underlying)
Holdings
  • Series C Preferred Stock

    Common Stock (497,809 underlying)
  • Series B Preferred Stock

    (indirect: See footnote)
    Common Stock (2,268,750 underlying)
  • Series B Preferred Stock

    Common Stock (231,250 underlying)
  • Series D Preferred Stock

    Common Stock (314,815 underlying)
Holdings
  • Series B Preferred Stock

    Common Stock (231,250 underlying)
  • Series C Preferred Stock

    Common Stock (497,809 underlying)
  • Series D Preferred Stock

    Common Stock (314,815 underlying)
  • Series B Preferred Stock

    (indirect: See footnote)
    Common Stock (2,268,750 underlying)
GUTHART LEO
10% Owner
Holdings
  • Series B Preferred Stock

    Common Stock (231,250 underlying)
  • Series D Preferred Stock

    Common Stock (314,815 underlying)
  • Series C Preferred Stock

    Common Stock (497,809 underlying)
  • Series B Preferred Stock

    (indirect: See footnote)
    Common Stock (2,268,750 underlying)
Footnotes (3)
  • [F1]Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date.
  • [F2]The shares are held of record by Topspin Fund, L.P. LG Management, LLC, the general partner of Topspin Fund, L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares.
  • [F3]The shares are held of record by Topspin Biotech Fund II, L.P. LG Management, LLC, the general partner of Topspin Biotech Fund II, L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares.

Issuer

Oric Pharmaceuticals, Inc.

CIK 0001796280

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001615782

Filing Metadata

Form type
3
Filed
Apr 22, 8:00 PM ET
Accepted
Apr 23, 8:25 PM ET
Size
13.5 KB